Array‐based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma

Array‐based comparative genomic hybridization (aCGH) allows the identification of DNA sequence copy number changes at high resolution by co‐hybridizing differentially labelled test and control DNAs to a micro‐array of genomic clones. The present study has analysed a series of 23 formalin‐fixed, paraffin wax‐embedded tissue samples of Barrett's adenocarcinoma (BCA, n = 18) and non‐neoplastic squamous oesophageal (n = 2) and gastric cardia mucosa (n = 3) by aCGH. The micro‐arrays used contained 287 genomic targets covering oncogenes, tumour suppressor genes, and DNA sequences localized within chromosomal regions previously reported to be altered in BCA. DNA sequence copy number changes for a panel of approximately 50 genes were identified, most of which have not been previously described in BCA. DNA sequence copy number gains (mean 41 ± 25/BCA) were more frequent than DNA sequence copy number losses (mean 20 ± 15/BCA). The highest frequencies for DNA sequence copy number gains were detected for SNRPN (61%); GNLY (44%); NME1 (44%); DDX15, ABCB1 (MDR), ATM, LAMA3, MYBL2, ZNF217, and TNFRSF6B (39% each); and MSH2, TERC, SERPINE1, AFM137XA11, IGF1R, and PTPN1 (33% each). DNA sequence copy number losses were identified for PDGFB (44%); D17S125 (39%); AKT3 (28%); and RASSFI, FHIT, CDKN2A (p16), and SAS (CDK4) (28% each). In all non‐neoplastic tissue samples of squamous oesophageal and gastric cardia mucosa, the measured mean ratios were 1.00 (squamous oesophageal mucosa) or 1.01 (gastric mucosa), indicating that no DNA sequence copy number chances were present. For validation, the DNA sequence copy number changes of selected clones (SNRPN, CMYC, HER2, ZNF217) detected by aCGH were confirmed by fluorescence in situ hybridization (FISH). These data show the sensitivity of aCGH for the identification of DNA sequence copy number changes at high resolution in BCA. The newly identified genes may include so far unknown biomarkers in BCA and are therefore a starting point for further studies elucidating their possible role in Barrett's carcinogenesis. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  Bauke Ylstra,et al.  Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high‐resolution microarray comparative genomic hybridization , 2003, The Journal of pathology.

[2]  D. Beer,et al.  Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas , 1997, Oncogene.

[3]  Carissa A. Sanchez,et al.  Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. , 1996, Oncogene.

[4]  Christopher P. Wild,et al.  Reflux, Barrett's oesophagus and adenocarcinoma: burning questions , 2003, Nature Reviews Cancer.

[5]  Holger Moch,et al.  Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. , 2003, The American journal of pathology.

[6]  R. Redon,et al.  Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer. , 2002, Cancer research.

[7]  M. Ringnér,et al.  Impact of DNA amplification on gene expression patterns in breast cancer. , 2002, Cancer research.

[8]  H. Höfler,et al.  Her-2/neu Gene Amplification, Elevated mRNA Expression, and Protein Overexpression in the Metaplasia-Dysplasia-Adenocarcinoma Sequence of Barrett’s Esophagus , 2001, Laboratory Investigation.

[9]  C. Lundsteen,et al.  Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals , 1999, Genes, chromosomes & cancer.

[10]  D. Coppola,et al.  Modification of insulin-like growth factor 1 receptor, c-Src, and Bcl-XL protein expression during the progression of Barrett's neoplasia. , 2003, Human pathology.

[11]  S. Saitoh,et al.  Imprinting in Prader-Willi and Angelman syndromes. , 1998, Trends in genetics : TIG.

[12]  Daniel Pinkel,et al.  Genomic microarrays in human genetic disease and cancer. , 2003, Human molecular genetics.

[13]  J R Siewert,et al.  Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. , 2000, The American journal of pathology.

[14]  F. Kokocinski,et al.  Automated Screening for Genomic Imbalances using Matrix-Based Comparative Genomic Hybridization , 2002, Laboratory Investigation.

[15]  Peter Lichter,et al.  Minimal sizes of deletions detected by comparative genomic hybridization , 1998, Genes, chromosomes & cancer.

[16]  Ho-Keung Ng,et al.  Detection of Multiple Gene Amplifications in Glioblastoma Multiforme Using Array-Based Comparative Genomic Hybridization , 2001, Laboratory Investigation.

[17]  M. Wolter,et al.  Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus. , 2001, American journal of clinical pathology.

[18]  A. Hui,et al.  Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. , 2002, International journal of oncology.

[19]  Wen-Lin Kuo,et al.  Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. , 2003, Cancer research.

[20]  Kenneth K Wang,et al.  Allelic imbalance of 7q32.3-q36.1 during tumorigenesis in Barrett's esophagus. , 2002, Cancer research.

[21]  J. Squire,et al.  Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. , 2003, Neoplasia.